Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $114.7400 (-0.48%) ($113.2300 - $115.5700) on Fri. Mar. 25, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.51% (three month average) | RSI | 73 | Latest Price | $114.7400(-0.48%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 0.6% a day on average for past five trading days. | Weekly Trend | LGND advances 4.9% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Rotation from growth to value for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(61%) IWO(61%) IWM(59%) IWC(57%) IWN(57%) | Factors Impacting LGND price | LGND will decline at least -1.755% in a week (0% probabilities). VIXM(-26%) UUP(-20%) VXX(-17%) TBT(-7%) UNG(-5%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.755% (StdDev 3.51%) | Hourly BBV | 0.5 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $113.21(1.35%) | 10 Day Moving Average | $110.3(4.03%) | 20 Day Moving Average | $106.05(8.19%) | To recent high | -29.6% | To recent low | 20.3% | Market Cap | $1.844b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |